"We're starting to now see, with tests like gene expression, that some combination of the polymer, or the polymer plus drug, is preventing the body from healing.

Mark Landy of MIV Therapeutics, on a possible source of problems with drug-eluting stents, "New polymer-free DES, with 60% less drug, effective in patients," pp. 1, 6.